• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌细胞外泌体分泌的突变 DNA 和 mRNA。

Secretion of Mutant DNA and mRNA by the Exosomes of Breast Cancer Cells.

机构信息

Department of Experimental Tumor Biology, Institute of Carcinogenesis, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia, 115522 Moscow, Russia.

Laboratory of Medical Genetics, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.

出版信息

Molecules. 2021 Apr 25;26(9):2499. doi: 10.3390/molecules26092499.

DOI:10.3390/molecules26092499
PMID:33922925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8123307/
Abstract

Exosomes are the small vesicles that are secreted by different types of normal and tumour cells and can incorporate and transfer their cargo to the recipient cells. The main goal of the present work was to study the tumour exosomes' ability to accumulate the parent mutant DNA or RNA transcripts with their following transfer to the surrounding cells. The experiments were performed on the MCF7 breast cancer cells that are characterized by the unique coding mutation in the gene. Using two independent methods, Sanger sequencing and allele-specific real-time PCR, we revealed the presence of the fragments of the mutant DNA and RNA transcripts in the exosomes secreted by the MCF7 cells. Furthermore, we demonstrated the MCF7 exosomes' ability to incorporate into the heterologous MDA-MB-231 breast cancer cells supporting the possible transferring of the exosomal cargo into the recipient cells. Sanger sequencing of the DNA from MDA-MB-231 cells (originally bearing a wild type of ) treated with MCF7 exosomes showed no detectable amount of mutant DNA or RNA; however, using allele-specific real-time PCR, we revealed a minor signal from amplification of a mutant allele, showing a slight increase of mutant DNA in the exosome-treated MDA-MB-231 cells. The results demonstrate the exosome-mediated secretion of the fragments of mutant DNA and mRNA by the cancer cells and the exosomes' ability to transfer their cargo into the heterologous cells.

摘要

外泌体是由不同类型的正常和肿瘤细胞分泌的小囊泡,可以整合并将其货物转移到受体细胞。本工作的主要目的是研究肿瘤外泌体积累亲本突变 DNA 或 RNA 转录本的能力及其随后向周围细胞的转移。该实验是在 MCF7 乳腺癌细胞上进行的,这些细胞的特点是在 基因中存在独特的编码突变。使用两种独立的方法,Sanger 测序和等位基因特异性实时 PCR,我们在 MCF7 细胞分泌的外泌体中发现了突变 DNA 和 RNA 转录本的片段。此外,我们还证明了 MCF7 外泌体能够将自身包裹的内容物转入异源 MDA-MB-231 乳腺癌细胞,支持外泌体货物向受体细胞转移的可能性。用 MCF7 外泌体处理的 MDA-MB-231 细胞(原本携带野生型 )的 DNA 的 Sanger 测序显示没有可检测到的突变 DNA 或 RNA 量;然而,使用等位基因特异性实时 PCR,我们从突变等位基因的扩增中检测到了一个微弱的信号,表明外泌体处理的 MDA-MB-231 细胞中突变 DNA 略有增加。这些结果表明肿瘤细胞通过外泌体介导的方式分泌突变 DNA 和 mRNA 的片段,以及外泌体将其货物转移到异源细胞的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/dcd9072cf40e/molecules-26-02499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/b2906741f495/molecules-26-02499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/886aad8fa6ae/molecules-26-02499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/4c982a204f1e/molecules-26-02499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/dcd9072cf40e/molecules-26-02499-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/b2906741f495/molecules-26-02499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/886aad8fa6ae/molecules-26-02499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/4c982a204f1e/molecules-26-02499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/8123307/dcd9072cf40e/molecules-26-02499-g004.jpg

相似文献

1
Secretion of Mutant DNA and mRNA by the Exosomes of Breast Cancer Cells.乳腺癌细胞外泌体分泌的突变 DNA 和 mRNA。
Molecules. 2021 Apr 25;26(9):2499. doi: 10.3390/molecules26092499.
2
Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.评估高转移性乳腺癌中靶向 PTEN 和 DUSP14 的外泌体 miR-9 和 miR-155 及其对低转移性细胞的影响。
J Cell Biochem. 2019 Apr;120(4):5666-5676. doi: 10.1002/jcb.27850. Epub 2018 Oct 18.
3
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.外泌体介导的miR-10b转移促进乳腺癌细胞侵袭。
Mol Cancer. 2014 Nov 26;13:256. doi: 10.1186/1476-4598-13-256.
4
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.间充质干细胞来源的外泌体携带 microRNA-100 通过调控乳腺癌细胞中的 mTOR/HIF-1α/VEGF 信号轴抑制体外血管生成。
Cell Oncol (Dordr). 2017 Oct;40(5):457-470. doi: 10.1007/s13402-017-0335-7. Epub 2017 Jul 24.
5
Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing.使用下一代测序技术对人乳腺癌细胞系分泌的外泌体中的 RNA 进行表征。
PeerJ. 2013 Nov 5;1:e201. doi: 10.7717/peerj.201. eCollection 2013.
6
Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.顺铂耐药 MDA-MB-231 细胞来源的外泌体以依赖外泌体 miR-423-5p 的方式增加受体细胞的耐药性。
Curr Drug Metab. 2019;20(10):804-814. doi: 10.2174/1389200220666190819151946.
7
Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells.高转移性细胞的外泌体 miRNA 可诱导非转移性细胞转移。
Life Sci. 2019 Mar 1;220:162-168. doi: 10.1016/j.lfs.2019.01.057. Epub 2019 Feb 2.
8
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).抗血管生成剂二十二碳六烯酸(DHA)可改变乳腺癌细胞中通过外泌体介导的微小RNA信号传导。
Mol Cancer. 2015 Jul 16;14:133. doi: 10.1186/s12943-015-0400-7.
9
Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.乳腺癌细胞来源的外泌体 miR-20a-5p 通过靶向 SRCIN1 促进破骨细胞的增殖和分化。
Cancer Med. 2019 Sep;8(12):5687-5701. doi: 10.1002/cam4.2454. Epub 2019 Aug 6.
10
A simple and robust real-time qPCR method for the detection of PIK3CA mutations.用于检测 PIK3CA 突变的简单而稳健的实时 qPCR 方法。
Sci Rep. 2018 Mar 9;8(1):4290. doi: 10.1038/s41598-018-22473-9.

引用本文的文献

1
The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA.细胞外囊泡相关DNA的检测、生物学功能及液体活检应用
Biomark Res. 2024 Oct 14;12(1):123. doi: 10.1186/s40364-024-00661-2.
2
Extracellular vesicle-associated DNA: ten years since its discovery in human blood.细胞外囊泡相关 DNA:在人类血液中发现十周年。
Cell Death Dis. 2024 Sep 12;15(9):668. doi: 10.1038/s41419-024-07003-y.
3
Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence.

本文引用的文献

1
Micronuclei as biomarkers of DNA damage, aneuploidy, inducers of chromosomal hypermutation and as sources of pro-inflammatory DNA in humans.微核作为 DNA 损伤、非整倍体、染色体超突变诱导物以及人类炎症性 DNA 来源的生物标志物。
Mutat Res Rev Mutat Res. 2020 Oct-Dec;786:108342. doi: 10.1016/j.mrrev.2020.108342. Epub 2020 Oct 28.
2
Total Blood Exosomes in Breast Cancer: Potential Role in Crucial Steps of Tumorigenesis.乳腺癌中的总血液外泌体:在肿瘤发生的关键步骤中的潜在作用。
Int J Mol Sci. 2020 Oct 5;21(19):7341. doi: 10.3390/ijms21197341.
3
Exosomes: key players in cancer and potential therapeutic strategy.
临床心力衰竭的干细胞治疗:精准医学与人工智能时代的新视角。
Front Physiol. 2024 Jan 9;14:1344885. doi: 10.3389/fphys.2023.1344885. eCollection 2023.
4
Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles.通过分析乳腺癌细胞外囊泡来破译其功能状态。
Int J Mol Sci. 2023 Aug 21;24(16):13022. doi: 10.3390/ijms241613022.
5
Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors.药物靶标治疗与脑膜肿瘤外泌体的新兴临床相关性。
Mol Cell Biochem. 2024 Jan;479(1):127-170. doi: 10.1007/s11010-023-04715-1. Epub 2023 Apr 4.
6
Small extracellular vesicles: from promoting pre-metastatic niche formation to therapeutic strategies in breast cancer.小细胞外囊泡:从促进癌转移前微环境形成到乳腺癌的治疗策略。
Cell Commun Signal. 2022 Sep 12;20(1):141. doi: 10.1186/s12964-022-00945-w.
7
Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy.乳腺癌中的外泌体:在肿瘤转移中的作用及液体活检的前景。
Int J Mol Sci. 2022 Aug 9;23(16):8845. doi: 10.3390/ijms23168845.
8
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy.外泌体介导的核酸递送至癌症治疗的最新进展。
J Nanobiotechnology. 2022 Jun 14;20(1):279. doi: 10.1186/s12951-022-01472-z.
9
Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance.探讨 ERα 靶向 miRNAs 在激素抵抗的外泌体介导转移中的作用。
Molecules. 2021 Nov 3;26(21):6661. doi: 10.3390/molecules26216661.
10
Mechanism of cargo sorting into small extracellular vesicles.货物分拣到小型细胞外囊泡的机制。
Bioengineered. 2021 Dec;12(1):8186-8201. doi: 10.1080/21655979.2021.1977767.
外泌体:癌症中的关键角色和潜在的治疗策略。
Signal Transduct Target Ther. 2020 Aug 5;5(1):145. doi: 10.1038/s41392-020-00261-0.
4
Selecting short length nucleic acids localized in exosomes improves plasma mutation detection in NSCLC patients.选择外泌体中定位的短链核酸可改善非小细胞肺癌患者血浆中的突变检测。
Cancer Cell Int. 2019 Oct 1;19:251. doi: 10.1186/s12935-019-0978-8. eCollection 2019.
5
Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation.人胰腺癌细胞外泌体,而非人正常细胞外泌体,在细胞转化中充当启动子。
Elife. 2019 May 28;8:e40226. doi: 10.7554/eLife.40226.
6
Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients.乳腺癌和卵巢癌患者循环外泌体中的蛋白酶货物
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):255-262. doi: 10.31557/APJCP.2019.20.1.255.
7
Exosome-Mediated Transfer of Cancer Cell Resistance to Antiestrogen Drugs.外泌体介导的癌细胞耐药性向抗雌激素药物的转移。
Molecules. 2018 Apr 4;23(4):829. doi: 10.3390/molecules23040829.
8
The Origin and Functions of Exosomes in Cancer.癌症中细胞外囊泡的起源与功能
Front Oncol. 2018 Mar 20;8:66. doi: 10.3389/fonc.2018.00066. eCollection 2018.
9
Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells.细胞质 DNA 酶的下调与衰老细胞中细胞质 DNA 的积累和 SASP 有关。
Nat Commun. 2018 Mar 28;9(1):1249. doi: 10.1038/s41467-018-03555-8.
10
KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.中国人群中结直肠癌患者血清外泌体中的KRAS和BRAF突变
Oncol Lett. 2017 May;13(5):3608-3616. doi: 10.3892/ol.2017.5889. Epub 2017 Mar 22.